Megan Shirey, Alexander Kwok, Holly Jenkins, Sami Uwaydat
{"title":"阿肯色州一项全州范围的远视性糖尿病视网膜病变筛查项目的研究结果。","authors":"Megan Shirey, Alexander Kwok, Holly Jenkins, Sami Uwaydat","doi":"10.1155/2023/3233803","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A significant proportion of diabetic patients in the United States do not present for annual dilated eye exams to monitor for signs of diabetic retinopathy (DR). The purpose of this study was to analyze the results of a statewide, multiclinic teleretina program designed to screen rural Arkansans for this sight-debilitating disease.</p><p><strong>Methods: </strong>Patients with diabetes seen at 10 primary care clinics across Arkansas were offered teleretinal-imaging services. Images were transmitted to the University of Arkansas for Medical Sciences' (UAMS) Harvey and Bernice Jones Eye Institute (JEI) for grading and recommendations for further treatment.</p><p><strong>Results: </strong>From February 2019 to May 2022, 668 patients underwent imaging; 645 images were deemed of sufficient quality to generate an interpretation. 541 patients had no evidence of DR, while 104 patients had some evidence of DR. 587 patients had no evidence of maculopathy, while 58 patients had some evidence of maculopathy on imaging. 246 patients had other pathology evident on imaging, with the most common being hypertensive retinopathy, glaucoma suspects, and cataracts. <i>Discussion</i>. In a rural, primary care setting, the JEI teleretina program identifies DR and other nondiabetic ocular pathologies, allowing for an appropriate triage for eye care for patients in a predominantly rural state.</p>","PeriodicalId":45630,"journal":{"name":"International Journal of Telemedicine and Applications","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065851/pdf/","citationCount":"1","resultStr":"{\"title\":\"Findings from a Statewide Teleretina Diabetic Retinopathy Screening Program in Arkansas.\",\"authors\":\"Megan Shirey, Alexander Kwok, Holly Jenkins, Sami Uwaydat\",\"doi\":\"10.1155/2023/3233803\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>A significant proportion of diabetic patients in the United States do not present for annual dilated eye exams to monitor for signs of diabetic retinopathy (DR). The purpose of this study was to analyze the results of a statewide, multiclinic teleretina program designed to screen rural Arkansans for this sight-debilitating disease.</p><p><strong>Methods: </strong>Patients with diabetes seen at 10 primary care clinics across Arkansas were offered teleretinal-imaging services. Images were transmitted to the University of Arkansas for Medical Sciences' (UAMS) Harvey and Bernice Jones Eye Institute (JEI) for grading and recommendations for further treatment.</p><p><strong>Results: </strong>From February 2019 to May 2022, 668 patients underwent imaging; 645 images were deemed of sufficient quality to generate an interpretation. 541 patients had no evidence of DR, while 104 patients had some evidence of DR. 587 patients had no evidence of maculopathy, while 58 patients had some evidence of maculopathy on imaging. 246 patients had other pathology evident on imaging, with the most common being hypertensive retinopathy, glaucoma suspects, and cataracts. <i>Discussion</i>. In a rural, primary care setting, the JEI teleretina program identifies DR and other nondiabetic ocular pathologies, allowing for an appropriate triage for eye care for patients in a predominantly rural state.</p>\",\"PeriodicalId\":45630,\"journal\":{\"name\":\"International Journal of Telemedicine and Applications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065851/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Telemedicine and Applications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/3233803\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Telemedicine and Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/3233803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Findings from a Statewide Teleretina Diabetic Retinopathy Screening Program in Arkansas.
Introduction: A significant proportion of diabetic patients in the United States do not present for annual dilated eye exams to monitor for signs of diabetic retinopathy (DR). The purpose of this study was to analyze the results of a statewide, multiclinic teleretina program designed to screen rural Arkansans for this sight-debilitating disease.
Methods: Patients with diabetes seen at 10 primary care clinics across Arkansas were offered teleretinal-imaging services. Images were transmitted to the University of Arkansas for Medical Sciences' (UAMS) Harvey and Bernice Jones Eye Institute (JEI) for grading and recommendations for further treatment.
Results: From February 2019 to May 2022, 668 patients underwent imaging; 645 images were deemed of sufficient quality to generate an interpretation. 541 patients had no evidence of DR, while 104 patients had some evidence of DR. 587 patients had no evidence of maculopathy, while 58 patients had some evidence of maculopathy on imaging. 246 patients had other pathology evident on imaging, with the most common being hypertensive retinopathy, glaucoma suspects, and cataracts. Discussion. In a rural, primary care setting, the JEI teleretina program identifies DR and other nondiabetic ocular pathologies, allowing for an appropriate triage for eye care for patients in a predominantly rural state.
期刊介绍：
The overall aim of the International Journal of Telemedicine and Applications is to bring together science and applications of medical practice and medical care at a distance as well as their supporting technologies such as, computing, communications, and networking technologies with emphasis on telemedicine techniques and telemedicine applications. It is directed at practicing engineers, academic researchers, as well as doctors, nurses, etc. Telemedicine is an information technology that enables doctors to perform medical consultations, diagnoses, and treatments, as well as medical education, away from patients. For example, doctors can remotely examine patients via remote viewing monitors and sound devices, and/or sampling physiological data using telecommunication. Telemedicine technology is applied to areas of emergency healthcare, videoconsulting, telecardiology, telepathology, teledermatology, teleophthalmology, teleoncology, telepsychiatry, teledentistry, etc. International Journal of Telemedicine and Applications will highlight the continued growth and new challenges in telemedicine, applications, and their supporting technologies, for both application development and basic research. Papers should emphasize original results or case studies relating to the theory and/or applications of telemedicine. Tutorial papers, especially those emphasizing multidisciplinary views of telemedicine, are also welcome. International Journal of Telemedicine and Applications employs a paperless, electronic submission and evaluation system to promote a rapid turnaround in the peer-review process.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
